Asia

The Society for Clinical Research Sites (SCRS) invites you to the virtual Asia Ambassador Symposium on 26 October 2024!

Join clinical research sites and industry professionals for virtual learning and collaboration as we address clinical research challenges and opportunities within Asia. Come away with actionable strategies for successful site operations including study coordination, partnership management, patient enrollment, and more.

SCRS Ambassador Symposiums unify key members of a regional site community for greater site sustainability.

This 3-hour livestream symposium will share how clinical research sites across East Asia are approaching clinical trial execution.

Sponsored By

SCRS Ambassador Symposium Session Agenda

26 October 2024 | 10:00-13:00 GMT +8 Beijing

Registration
10:00 – 10:15 Welcome and Opening Remarks
Speakers:
Dan Milam, VP, Global Head of Site Engagement, Sigla Therapeutics
Li-Yuan Bai, M.D., M.M.S., Ph.D., Director of Hematology and Oncology and Deputy Director of Clinical Trial Center, China Medical University Hospital
10:15 – 11:00 SCRS and the Site Landscape in Asia
Speakers:
Li-Yuan Bai, M.D., M.M.S., Ph.D., Director of Hematology and Oncology and Deputy Director of Clinical Trial Center, China Medical University Hospital
Tanya Kogan, Senior Product Manager, Greenphire
Dan Milam, VP, Global Head of Site Engagement, Sigla Therapeutics
Michael Pierre, Project Manager, SCRS
11:00 – 11:50 Benefits, Drawbacks, and Myths of Decentralized Clinical Trials
Speakers:
Merissa Govender, Global Innovation Lead, Sanofi
Chia-Chi (Josh) Lin, MD, PhD, Attending Physician, National Taiwan University Hospital Cancer Center
11:50 – 12:00 Break
12:00 – 12:50 Clinical Trials In Asia – Opportunities and Challenges

Breakout Sessions
Speakers:
Hsin-An Hou, MD, PhD, Attending Physician, Department of Internal Medicine, National Taiwan University Hospital
Aritra Bhowmik, BCMAS, MBA, Site Success Manager – Global Medical Affairs, Cognizant Technology Solutions
Chia-Jui Yen, MD, PhD, Director of  Cancer Center, Department of Oncology, National Cheng Kung University Hospital

12:50 – 13:00 Closing Remarks
Speakers:
Dan Milam, VP, Global Head of Site Engagement, Sigla Therapeutics
Li-Yuan Bai, M.D., M.M.S., Ph.D., Director of Hematology and Oncology and Deputy Director of Clinical Trial Center, China Medical University Hospital

Why Attend?

Receive a one-year SCRS Membership for your site*

Network and collaborate with sites and industry partners

Discover technologies to scale your site operations

Build your site’s research capacity and resources

Who Should Attend?

Clinical research sites and industry professionals located in Asia, including:

  • Site Owners & Managers
  • Clinical Investigators & Physicians
  • Patient-Facing Teams
  • Site Operations
  • Business Development
  • Regulatory & Government Affairs

About the SCRS Ambassador Program

The SCRS Ambassador Program is designed to cultivate a network of influential research industry professionals who will serve as SCRS ambassadors, bridging the gap between clinical research sites within their respective regions.

The Ambassador Program supports the global site community and other industry stakeholders by providing active and ongoing dialogue and content exchange. By attending Ambassador Symposiums, regional site attendees will have access to all SCRS member benefits for their entire organization.

Ambassador Program Asia Regional Lead

Li-Yuan Bai, M.D., M.M.S., Ph.D.

Prof. Bai graduated from the National Yang-Ming University School of Medicine in 1987 and completed the PhD program at China Medical University in 2011.

Since 2005, he served as a visiting staff at the Division of Hematology and Oncology in China Medical University Hospital in Taiwan. Currently, he is the Director of the Hematology and Oncology division, and Vice Director of the Clinical Trial Center at China Medical University Hospital. The professional fields of Dr. Bai include cancer of gastrointestinal tract, pancreas, biliary tract, gastrointestinal stromal tumor, and neuroendocrine tumor. He has participated many global clinical trials in relevant fields and is the leading principal investigator in three PI-initiated clinical trials. Prof. Bai is also active in first-in-human and early phase clinical trials, with the engagement of 34 first-in-human or phase I trials between 2014 to 2022. Prof. Bai has published more than 120 peer-reviewed articles, including Lancet, Lancet Oncol, J Clin Oncol, Ann Oncol, Cancer Res, Clin Cancer Res, Biochem Pharmacol, and Cancer Cell Int, et al.

*Qualified site attendees will receive a one-year digital SCRS membership scholarship for your location. To qualify, you must be currently working at a site located within the named SCRS Ambassador region. (Sites located or headquartered in any other geography are not eligible). SCRS membership benefits will be available to all registered staff at your physical location. SCRS membership benefits are not transferable from originating SCRS Ambassador scholarship award.

Questions? Contact Michael Pierre at michael.pierre@myscrs.org